Alpha Teknova, Inc. (TKNO) investor relations documents from the company's IR site: 1 presentation, 7 press releases; latest deck 2026-08-11. Read in-app with summaries. First-party data.
Company Overview: Teknova provides critical reagents for life sciences, guiding 2026 revenue of $45-47 million with 14% growth and a path to positive quarterly Adjusted EBITDA in 2027.
| Published | Type | Document |
|---|---|---|
| 2026-08-11 | Presentation | Company Overview |
| 2026-08-05 | Press release | Teknova Reports Second Quarter 2026 Financial Results |
| 2026-08-05 | Press release | Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Produc |
| 2026-07-22 | Press release | Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026 |
| 2026-05-06 | Press release | Teknova Reports First Quarter 2026 Financial Results |
| 2026-04-22 | Press release | Teknova to Report First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-02-26 | Press release | Teknova Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-05 | Press release | Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 |
TKNO overview · TKNO earnings · TKNO financials · TKNO KPIs · TKNO documents · TKNO ownership · TKNO peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.